板球和黑水虻幼虫强化饼干对马达加斯加学龄儿童肠道微生物组和铁状况的影响
板球与黑水虻幼虫强化饼干对马达加斯加学龄儿童肠道微生物组及铁状况的影响
The purpose of this study is to determine the health impacts of consistent consumption of insect-fortified crackers among school-aged children in Madagascar.
Specifically, in this RCT, the investigators will assess whether the insect-fortified crackers can improve the health status of Malagasy school children. The investigators' objectives are to: (1) Assess changes in gut microbiome composition that occur after 6 and 14 weeks of cracker consumption through 16S rRNA sequencing. (2) Assess changes in intestinal and systemic inflammation after 6 and 14 weeks of cracker consumption through quantification of fecal calprotectin, lactoferrin, myeloperoxidase (MPO), and alpha-1-antitrypsin (AAT) and circulating pro-inflammatory cytokines. (3) Assess changes in iron status after 14 weeks of cracker consumption through quantification of hemoglobin (Hb), inflammation-adjusted serum ferritin, and soluble transferrin receptor (sTfR).
研究概览
地位
详细说明
Food insecurity, child malnutrition, and anemia remain significant public health problems globally, including in Madagascar where 40% of children under 5 years of age are chronically malnourished (stunted), 8% are wasted, and 46% are anemic (DHS, 2021). Interventions aimed at addressing this have often foundered on the fact that the foods that would address these nutrient deficiencies are physically unavailable, too expensive for poor households to purchase, or contribute to climate change or environmental degradation. Consequently, there is interest in the development of novel food products that could contribute to reducing malnutrition in all its forms, without the drawbacks of relying on existing food products. One possibility is to develop food products based on insects. Edible insects are low-cost, climate friendly, with nutritional profiles akin to meat. They contain high amounts of protein, iron, and zinc while also providing a novel source of prebiotic fiber. It is hypothesized that insect-based foods could improve children's health outcomes as measured by gut inflammation, anemia, and growth. The investigators and others have developed an insect-fortified cracker snack, suitable for the nutritional requirements of school-age children living in Southeast Madagascar. The investigators have already assessed the product's nutrient profile. They also have documented the safety tests done to date; these show that the snack is safe for human consumption. The test results have been submitted to the Malagasy regulatory authority for registering food and health products and the government has approved the insect powders as food for human consumption and issued "Certificates for Human Consumption". The investigators have also conducted an acceptability trial that showed that child participants like the organoleptic characteristics of the crackers and regularly consume the crackers in biologically meaningful quantities.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Vakinankaratra Region
-
Antsirabe、Vakinankaratra Region、马达加斯加
- FSRP Sschools
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion criteria for children
- Child (male, female, intersex, non-binary), aged 9 to 13 years old who attends one of the selected schools
- Caregiver or legal guardian is willing to provide informed consent
- Child is willing to provide informed assent
Exclusion criteria for children
- Child age is outside the preferred age range (9 to 13 years)
- Not enrolled in the participating schools
- Unable or unwilling to comply with the study requirements
- Illness requiring medical treatment, malaria, severe anemia (hemoglobin (Hb) concentration below 8.0 g/dL as indicated by HemoCue 201+ system), severe acute malnutrition, fever, diarrhea, etc.
- Covid-exposure or symptoms: loss of smell or taste
- History of food allergies or adverse reactions to any edible insects
- Chronic severe medical condition or congenital anomalies requiring frequent medical attention or interfering with dietary consumption
- Caregiver does not give consent, or child does not assent
Inclusion criteria for parents • Willing to participate in completing surveys about demographics and household dynamics (assets, housing structure, etc.)
Exclusion criteria for parents
• Caregiver does not consent to participate
学习计划
研究是如何设计的?
设计细节
- 主要用途:基础科学
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Treatment
Consumption of insect-fortified (crickets and black soldier fly larvae) crackers. |
Children will receive a sachet containing 50g of insect crackers. 50 grams was chosen as the amount because the investigators know, from their earlier acceptability trial, that children are willing to consume this amount (in the acceptability trial, approximately 80% of children consumed 80% or more of the 50g of crackers that they were provided). Crackers will be provided Monday-Friday for approximately 14 weeks.
其他名称:
|
|
安慰剂比较:Control
Consumption of rice and corn crackers |
Children will receive a sachet containing 50g of insect crackers. 50 grams was chosen as the amount because the investigators know, from their earlier acceptability trial, that children are willing to consume this amount (in the acceptability trial, approximately 80% of children consumed 80% or more of the 50g of crackers that they were provided). Crackers will be provided Monday-Friday for approximately 14 weeks.
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Gut mircrobiome
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess gut microbiome composition at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through 16S rRNA sequencing and quantification of fecal biomarkers. |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Iron via soluble transferrin receptor
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess iron status at baseline (0 weeks) and endline (14 weeks) through soluble transferrin receptor (mg/L). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Intestinal inflammation via calprotectin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess intestinal inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through the quantification of following fecal marker: calprotectin (µg/g). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Intestinal inflammation via lactoferrin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess intestinal inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through the quantification of following fecal marker: lactoferrin (µg/g). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Intestinal inflammation via lipocalin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess intestinal inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through the quantification of following fecal marker: lipocalin (ng/g). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Intestinal inflammation via anlpha-1 antitrypsin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess intestinal inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through the quantification of following fecal marker: anlpha-1 antitrypsin (mg/g). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Intestinal inflammation via myeloperoxidase
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess intestinal inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through the quantification of following fecal marker: myeloperoxidase (µg/g). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Systemic inflammation via quantification of circulating cytokines
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will also assess systemic inflammation at baseline (0 weeks), midline (6 weeks), and endline (14 weeks) through quantification of circulating cytokines, including IL-1β, IL-2, IL-4, IL-6, IL-10, IL-22, TNF-α, IFN-γ, CCL2, all expressed as pg/mL. |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Iron via quantification of hemoglobin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess iron status at baseline (0 weeks) and endline (14 weeks) through quantification of hemoglobin (g/dL). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
|
Iron via inflammation adjusted ferritin
大体时间:From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
The investigators will assess iron status at baseline (0 weeks) and endline (14 weeks) through inflammation adjusted ferritin (µg/L). |
From enrollment to the end of treatment after 14 weeks of cracker consumption.
|
合作者和调查者
调查人员
- 学习椅:John Hoddinott, DPhil、Cornell University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- IRB0149913
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 共享时间框架
July 2026 to July 2027
IPD 共享支持信息类型
- 研究方案
- 树液
- 国际碳纤维联合会
- 分析代码
- 企业社会责任
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.